Greater occipital nerve blocks may alleviate photophobia brought on by migraines Dr. Kamal Kant Kohli1 Oct 2022 11:15 AM ISTSPAIN: According to a research study published in the Journal of Neuro-Ophthalmology, greater occipital nerve block reduces migraine-related...
Ubrogepant best treatment option for relieving mild migraine pain: Study Jacinthlyn Sylvia1 Sept 2022 10:15 AM ISTUSA: A new study published in Neurology found that ubrogepant treatment against mild migraine pain resulted in greater pain relief, symptomatic...
Soy isoflavones supplementation helps fight migraine in women: BMC Jacinthlyn Sylvia8 Aug 2022 9:30 AM ISTA new study published in BMC Nutrition Journal suggests that supplementing with soy isoflavones may be thought of as an additional therapy for...
Cipla gets CDSCO panel nod to study Rizatriptan Benzoate Orally Disintegrating Tablet Rahul Verma4 Aug 2022 6:00 PM ISTGranting approval to conduct bioequivalence (BE) study of Rizatriptan Benzoate Orally Disintegrating Tablets 5mg, the Subject Expert Committee (SEC)...
Cipla Secure CDSCO Panel Nod To Study Rizatriptan Benzoate Orally Disintegrating Tablet Dr. Divya Colin3 Aug 2022 6:00 PM ISTNew Delhi: Granting approval to conduct bioequivalence (BE) study of Rizatriptan Benzoate Orally Disintegrating Tablets 5mg, the Subject Expert...
External concurrent occipital and trigeminal neurostimulation relieves migraine pain: Study Jacinthlyn Sylvia21 July 2022 9:15 AM ISTUSA: In a randomized environment, external concurrent occipital and trigeminal neurostimulation offered quick and lasting relief and freedom from...
AbbVie seeks EMA approval for Atogepant for prophylaxis treatment of Migraine Ruchika Sharma19 July 2022 1:45 PM ISTAtogepant is an orally administered, CGRP receptor antagonist (gepant) specifically developed for the prophylaxis treatment of migraine.
B compilex vitamins effective for prophylaxis of episodic migraines in women Medha Baranwal30 Jun 2022 9:30 AM ISTIran: The use of vitamins B1, B6, B12, and B9, and a combination of these vitamins could be an effective adjuvant treatment and prophylaxis of...
Prenatal triptan exposure not tied to ADHD risk among offsprings, finds JAMA study Jacinthlyn Sylvia23 Jun 2022 9:45 AM ISTNorway: A new study published in the Journal of American Medical Association (JAMA) suggests that there is no increase in the risk of...
AbbVie files sNDA to USFDA for Atogepant for chronic migraine treatment Ruchika Sharma22 Jun 2022 1:30 PM ISTNorth Chicago, Ill.: AbbVie has announced that the company has submitted a supplemental New Drug Application (sNDA) for atogepant (QULIPTA) to the...
Lidocaine infusions help relieve pain in unresponsive chronic migraine Dr. Kamal Kant Kohli19 Jun 2022 7:30 PM ISTInfusions of the local anesthetic lidocaine may provide some pain relief to people with chronic migraine that does not respond to other treatments,...
Atogepant- new solution for migraines Jacinthlyn Sylvia17 Jun 2022 9:15 AM ISTUSA: In a new article published in the Journal of American Medical Association, atogepant was shown to be effective and well-tolerated for the...
